Positive Development
Mclean, US · Founded 2020 · Delaware corporation · 9 known investors
Positive Development provides autism therapy and developmental care services for neurodivergent children and their families. The company delivers evidence-based care through a multidisciplinary team approach focused on supporting both the child and whole family.
Founders & leadership
MS

Mike SuitersExecutive Officer, Director
NW
Nick WhiteheadDirector
BF
Brenton FargnoliDirector
AS
Adam SeabrookDirector
DG
Daniel GebremedhinDirector
JB

John BantaDirector
RB
Roy BeveridgeDirector
MP
Mark PacalaDirector
Investors · 9
AlleyCorpNew York · $1M – $5M
B Capital GroupManhattan Beach · $10M – $50Mvia Nick Whitehead · board
B4 Capital$10M – $50M
Flare Capital PartnersBoston · $1M – $10M
Lifeforce CapitalChevy Chase · $500K – $5M
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred
B Capital GroupreportedManhattan Beach · $100K – $60M
BlueCross BlueShield Venture PartnersreportedChicago
Digitalis VenturesreportedNew York · $100K – $10M
Reported raises · per SEC filings
Form D private placements▶$22MraisedJan 2025 · 4 investors · OtherRule 506(b)
▶$22MraisedJan 2025 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Adam SeabrookDirector
- Roy BeveridgeDirector
- Mark PacalaDirector
- Daniel GebremedhinDirector
- Mike SuitersExecutive Officer, Director
- John BantaDirector
- Nick WhiteheadDirector
- Offering amount
- $30M
- Amount sold
- $22M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$10MraisedJun 2024 · 6 investors · OtherRule 506(b)
▶$10MraisedJun 2024 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Roy BeveridgeDirector
- Mike SuitersExecutive Officer, Director
- Mark PacalaDirector
- Adam SeabrookDirector
- Daniel GebremedhinDirector
- John BantaDirector
- Brenton FargnoliDirector
- Offering amount
- $11.9M
- Amount sold
- $10M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$37.3MraisedNov 2022 · 10 investors · OtherRule 506(b)
▶$37.3MraisedNov 2022 · 10 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Daniel GebremedhinDirector
- Mike SuitersExecutive Officer, Director
- Mark PacalaDirector
- Roy BeveridgeDirector
- John BantaDirector
- Adam SeabrookDirector
- Brenton FargnoliDirector
- Offering amount
- $37.3M
- Amount sold
- $37.3M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.9MraisedJan 2021 · 16 investors · OtherRule 506(b)
▶$2.9MraisedJan 2021 · 16 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mike SuitersExecutive Officer, Director
- John BantaDirector
- Mark PacalaDirector
- Brenton FargnoliDirector
- Roy BeveridgeDirector
- Offering amount
- $3M
- Amount sold
- $2.9M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Top digital health funding: Vista AI, Positive Development - Modern Healthcaremodernhealthcare.com · 2026
- McLean’s Positive Development secures $45M in new funding for autism therapy expansion - Washington Business Journalbizjournals.com · 2026
- ABA Alternative Positive Development Closes $45M in Debt Financing - Behavioral Health Businessbhbusiness.com · 2026
- Positive Development Rakes In $51.5M To Grow Developmental Therapy Model for Autism - MedCity Newsmedcitynews.com · 2025
- Positive Development Raises $51.5M to Expand Nation’s Leading Developmental Therapy Model for Autismbusinesswire.com · 2025
- Positive Development Raises $51.5M Fundingfinsmes.com · 2025